APNewsBreak: Top Executive Out at Medical Marijuana Company

1y
2m read
Summary

AdvertisementSupported byAPNewsBreak: Top Executive Out at Medical Marijuana CompanyBy The Associated PressMay 10, 2018ST. PAUL, Minn. — The chief executive of one of Minnesota's two medical marijuana manufacturers has left the company after years of financial losses.Andrew Bachman, LeafLine Labs' co-founder and its chief executive since 2016, is no longer with the company "in any official capacity," the company said in a Thursday statement to The Associated Press. LeafLine was one of two manufacturers selected to grow and cultivate medical marijuana in 2014, the year Minnesota's Legislature passed its law.Minnesota's program is among the most restrictive of 30 states that allow medical marijuana. Bachman was the company's fourth chief executive since the company formed in 2014. Bachman didn't respond to a voicemail or text message seeking comment.But LeafLine has struggled since medical marijuana sales began in 2015 in Minnesota. He took over after Manny Munson-Regala, previously a top state regulator of the medical marijuana industry, left the company in 2016 after just eight months on the job.Last fall, the company's chief medical officer and chief financial officer resigned, with Bachman citing "personal and professional reasons."Advertisement

Article Preview

Advertisement

Supported by

APNewsBreak: Top Executive Out at Medical Marijuana Company

By The Associated Press

May 10, 2018

ST. PAUL, Minn. — The chief executive of one of Minnesota's two medical marijuana manufacturers has left the company after years of financial losses.

Andrew Bachman, LeafLine Labs' co-founder and its chief executive since 2016, is no longer with the company "in any official capacity," the company said in a Thursday statement to The Associated Press. The company's entire 5-member board has also been replaced.

The statement didn't give a reason for Bachman's exit, and a...

Read the full article @ NY Times